IRS-ISIAN 2024 | Targeting Type 2 Inflammation: Managing Smell Loss and Congestion in Patients With Recurrent CRSwNP
Prof. Joaquim Mullol reports on biologic improvements in sense of smell and nasal congestion in patients with and without a history of endoscopic sinus surgery.
Learning objectives
- Evaluate biologic data on improvements in smell loss and congestion in patients with recurrent CRSwNP
Description
Join Prof. Joaquim Mullol as he discusses multiple biologics that target type 2 inflammation in occurences of smell loss and nasal congestion in patients with uncontrolled and/or severe CRSwNP.
About this expert
Joaquim Mullol
Director of the Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology | Hospital Clinic, Barcelona, Spain; Professor of Research and Head of the Laboratory of Clinical and Experimental Respiratory Immunoallergy | August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain | Head of Research Group at Biomedical Research Network on Respiratory Diseases (CIBERES) | Carlos III Institute of Health, Barcelona, Spain
See author’s profileRelated resources
